Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
4
×
life sciences
national
4
×
national blog main
cancer immunotherapy
novartis
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicaid
medicare
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
samit hirawat
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
What
year
4
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
plan
price
progress
scrip
spoke
squibb
trial
alzheimer’s
answer
away
bio
companies
democratic
dems
different
discontent
drug
drugs
election
fail
gene
high
Language
unset
Current search:
cancer
×
year
×
national
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
